Fayez Sarofim & Co’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $560K | Sell |
5,216
-425
| -8% | -$45.6K | ﹤0.01% | 223 |
|
|
2025
Q1 | $569K | Buy |
5,641
+290
| +5% | +$29.3K | ﹤0.01% | 223 |
|
|
2024
Q4 | $478K | Buy |
5,351
+1,558
| +41% | +$139K | ﹤0.01% | 234 |
|
|
2024
Q3 | $318K | Sell |
3,793
-8,926
| -70% | -$748K | ﹤0.01% | 252 |
|
|
2024
Q2 | $979K | Sell |
12,719
-7
| -0.1% | -$539 | ﹤0.01% | 172 |
|
|
2024
Q1 | $872K | Buy |
12,726
+7
| +0.1% | +$479 | ﹤0.01% | 175 |
|
|
2023
Q4 | $833K | Sell |
12,719
-1,324
| -9% | -$86.7K | ﹤0.01% | 176 |
|
|
2023
Q3 | $741K | Buy |
14,043
+8,935
| +175% | +$472K | ﹤0.01% | 180 |
|
|
2023
Q2 | $276K | Buy |
+5,108
| New | +$276K | ﹤0.01% | 252 |
|